Private foundation
MINNEAPOLIS, MNEIN
The funder's latest Form 990-PF says it accepts applications. Read the instructions below before you write.
Application policy: Accepts applications, as stated on the FY2025 return.
These lines count this foundation's own Form 990-PF returns that the IRS has published as data. An amended return replaces its original. They describe past returns only.
This is a count from past returns. It does not say the foundation will consider a new request. How it is counted: names are compared as written on the returns, without "The" at the start, without endings such as "Inc" or "LLC", and without spaces and punctuation. A recipient also counts as already listed when our records link it to the same organization as an earlier recipient, or when its name is almost the same as an earlier name (a trigram similarity of 0.8 or more, where 1 means identical). The state on the grant row is not compared. Grants that the foundation marked as paid to an individual, such as a scholarship, are left out of both numbers, and no count is shown when most of its grants are marked that way. A person whom the foundation did not mark as an individual is still counted as a recipient. A recipient can still look new when its name is written very differently from year to year, and two different recipients with almost the same name can be counted as one.
Application guidance comes from the funder's own Form 990-PF, Part XV (the section where a private foundation says how to apply), shown as filed. It is the funder's words, not ours. These fields are free text and the IRS form cuts them short. Filers sometimes put whole sentences in the contact-name box. Shown exactly as filed.
Giving by year
Total assets by year
| Year | Form | Revenue | Expenses | Giving | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2025 | 990-PF | $573,234 | $598,619 | $583,451 | $14,760,453 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
Recipient focus areas
Where recipients are
Based on the 3% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| OHSU FoundationPortland, OR | Using Linked Organ-on-a-Chip Technology to Investigate Microbial Estrogen Metabolism as a Driver of Breast Cancer and Potential Interventions, Danielle Konetski Brasino, PhD | $30,000 | 2022 | |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Truman Collins Jr | TRUSTEE | 1.00 | $0 |
| Virginia Tilden | TRUSTEE | 1.00 | $2,000 |
| Ryan Luria | TRUSTEE | 1.00 | $0 |
| Tamara Potruch | ADMINISTRATOR |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| $14,628,959 |
| FY2024 | 990-PF | $414,132 | $592,315 | $585,547 | $12,992,665 | $12,890,097 |
| FY2023 | 990-PF | $843,068 | $680,095 | $665,944 | $10,957,538 | $10,891,116 |
| FY2022 | 990-PF | $1,521,870 | $503,165 | $481,585 | $10,569,529 | $10,495,846 |
| FY2021 | 990-PF | $857,977 | $514,594 | $502,207 | $11,287,726 | $11,189,045 |
| FY2020 | 990-PF | $1,049,815 | $507,698 | $496,768 | $8,321,355 | $8,262,238 |
| FY2019 | 990-PF | $425,910 | $522,010 | $517,289 | $8,737,370 | $8,686,365 |
| FY2018 | 990-PF | $633,569 | $560,293 | $553,573 | $9,604,926 | $9,543,907 |
| FY2017 | 990-PF | $324,836 | $522,331 | $517,220 | $9,760,156 | $9,703,121 |
| FY2016 | 990-PF | $887,620 | $475,573 | $466,367 | $8,541,451 | $8,488,724 |
| OHSU FoundationPortland, OR |
| Optimizing a low-protein diet to elicit retinal neuroprotectionRenee Ryals, PhD |
| $30,000 |
| 2021 |
| OHSU FoundationPortland, OR | The Development of Commensal Bacteria as Non-Invasive, Cancer-Sensing ProbesMichael Brasino, PhD | $30,000 | 2021 |
| OREGON STATE UNIVERSITYCORVALLIS, OR | Microbiome-mediated effects of human Amyloid Precursor Protein (APP) mutations on behavioral and cognitive performance, Payel Kundu, PhD | $30,000 | 2020 |
| PROVIDENCE COMMUNITY HEALTH FOUNDATMEDFORD, OR | Nursing Education Fund | $30,000 | 2022 |
| OHSU FoundationPortland, OR | A novel role for thyroid hormone signaling in the regulation of sex differences in addiction, Deena Walker, PhD | $30,000 | 2021 |
| OHSU FoundationPortland, OR | Neuroprotective Mechanisms of Dark-Rearing in Retinitis Pigmentosa - Paul Yang, MD, PhD | $30,000 | 2017 |
| OHSU FoundationPortland, OR | Alpha-synuclein aggregate pathology in the vocal communication system in a mouse model of Parkinsons disease - Allison Schaser, PhD, CCC-SLP | $30,000 | 2018 |
| PROVIDENCE PORTLAND MEDICAL FDNPortland, OR | Linking B Cell Immune Phenotype to Radiation Response in Rectal Cancers - Andrew Gunderson, PhD | $30,000 | 2017 |
| OHSU FoundationPortland, OR | Prediction of bacterial effectors targeting the host ubiquitin signaling response - Jonathan Pruneda, PhD | $30,000 | 2019 |
| OHSU FoundationPortland, OR | LRRK2-mediated Neurodegeneration in Parkinsons DiseaseIan Martin, PhD | $30,000 | 2019 |
| OHSU FoundationPortland, OR | Multi-omic Analysis of Decitabine Resistance in FLT-3 Mutated Acute Myeloid Leukemia, Qiuying (Selina) Liu, MD/OHSU | $30,000 | 2023 |
| OHSU FoundationPortland, OR | Overcoming Ruxolitinib Resistance in Chronic Neutrophilic LeukemiaSarah Carratt, PhD | $30,000 | 2020 |
| PROVIDENCE PORTLAND MEDICAL FDNPortland, OR | STING activation in the treatment of locally advanced and borderline pancreatic cancer - Ephraim Tang, MD | $30,000 | 2018 |
| OHSU FOUNDATIONPORTLAND, OR | EXPLORING THE DYNAMIC 3D GENOMIC LANDSCAPES IN BIALLELIC CEBPA MUTANT MYELOID MALIGNANCIES | $30,000 | 2024 |
| PORTLAND VA RESEARCH FOUNDATIONPORTLAND, OR | Using Social Media to Engage At-Risk Veterans in Mental Health Treatment, Alan R. Teo, MD, MS | $30,000 | 2016 |
| OHSU FoundationPortland, OR | Disruptions in SNARE-dependent Exocytosis and N-methyl-D-aspartate Receptor Localization as a Novel Pathophysiology in Alzheimers Disease, Ursula Sandau, PhD | $30,000 | 2023 |
| OHSU FoundationPortland, OR | Advanced Single-cell Proteogenomic Approaches to Studying microglial heterogeneity in Alzheimers Disease, Bahareh Ajami, PhD | $30,000 | 2020 |
| OHSU FoundationPortland, OR | Genetic approaches to study tumor-derived extracellular vesicles and their role in generating tumor-promoting antibodies, - Ferdinando Pucci, PhD | $30,000 | 2019 |
| OHSU FoundationPortland, OR | Reprogramming Tumor Associated Macrophages by Inhibiting Cholesterol Metabolism for Reinvigoration of the Immune System in Malignant Mesothelioma for Reinvigoration of the Immune System in Malignant Mesothelioma, Sushil Kumar, PhD | $30,000 | 2016 |
| OHSU FoundationPortland, OR | Type I/III interferons in mucosal immunity to enteric viral infection, Timothy Nice, PhD | $30,000 | 2016 |
| PORTLAND VA RESEARCH FOUNDATIONPORTLAND, OR | Investigating the role of platelets in venous thrombus resolution and post-thrombotic vein wall fibrosis - Khanh P. Nguyen, MD | $30,000 | 2019 |
| OHSU FoundationPortland, OR | Enzyme-Responsive Nanoparticles for Dentin Collagen Preservation Ana Paula Piovezan Fugolin, DDS, MS, PhD | $30,000 | 2021 |
| GOOD SAMARITAN FOUNDATIONPORTLAND, OR | Comparing Axon Transport and Cytoskeletal Ultrastructure by Transmission Electron Microscopy, Laura J. Wilsey, PhD | $30,000 | 2016 |
| OHSU FoundationPortland, OR | Unexpected proliferation of cardiac myocytes following neonatal aortic coarctation, Sonnet Jonker, PhD | $30,000 | 2016 |
| 1.00 |
| $0 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990-PF · FY2024 · period ending Sep 30, 2024IRS bulk XML
Filing id 202510419349100106
Form 990-PF · FY2023 · period ending Sep 30, 2023
Filing id 202332929349100908
Form 990-PF · FY2022 · period ending Sep 30, 2022
Filing id 202310349349100701
Form 990-PF · FY2021 · period ending Sep 30, 2021
Filing id 202221589349101702
Form 990-PF · FY2020 · period ending Sep 30, 2020
Filing id 202110359349100411
Form 990-PF · FY2019 · period ending Sep 30, 2019
Filing id 202040389349101019
Form 990-PF · FY2018 · period ending Sep 30, 2018
Filing id 201920369349100602
Form 990-PF · FY2017 · period ending Sep 30, 2017
Filing id 201820339349100202
Form 990-PF · FY2016 · period ending Sep 30, 2016
Filing id 201710449349100226
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.